{"id":"https://openalex.org/W2588604651","doi":"https://doi.org/10.1182/blood.v112.11.5234.5234","title":"Increased Intramedullary T Cells Corresponds with Response to Thalidomide (THAL) Therapy in Primary Myelofibrosis","display_name":"Increased Intramedullary T Cells Corresponds with Response to Thalidomide (THAL) Therapy in Primary Myelofibrosis","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2588604651","doi":"https://doi.org/10.1182/blood.v112.11.5234.5234","mag":"2588604651"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.5234.5234","doi":"https://doi.org/10.1182/blood.v112.11.5234.5234","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.5234.5234","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben A. Mesa","raw_affiliation_strings":["Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111801384","display_name":"Chin\u2010Yang Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chin Yang Li","raw_affiliation_strings":["Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045789519","display_name":"Susan Marie Schwager","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Schwager","raw_affiliation_strings":["Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016216479","display_name":"Ayalew Tefferi","orcid":"https://orcid.org/0000-0003-4605-3821","observed_orcids":["https://orcid.org/0000-0003-4605-3821"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ayalew Tefferi","raw_affiliation_strings":["Medicine, Division of Hematology, Mayo Clinic Graduate School of Medicine, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Division of Hematology, Mayo Clinic Graduate School of Medicine, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.40236192,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"112","issue":"11","first_page":"5234","last_page":"5234"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-myelofibrosis","display_name":"primary myelofibrosis","score":0.9769999980926514},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.996999979019165},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9779999852180481},{"id":"https://openalex.org/keywords/immunomodulatory-therapy","display_name":"immunomodulatory therapy","score":0.8169999718666077},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.5960000157356262},{"id":"https://openalex.org/keywords/reticulin-fibrosis","display_name":"reticulin fibrosis","score":0.7870000004768372},{"id":"https://openalex.org/keywords/megakaryocyte-dysplasia","display_name":"megakaryocyte dysplasia","score":0.8289999961853027},{"id":"https://openalex.org/keywords/corticosteroid-combination-therapy","display_name":"corticosteroid combination therapy","score":0.6970000267028809},{"id":"https://openalex.org/keywords/prognostic-scoring","display_name":"prognostic scoring","score":0.6039999723434448},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.3100000023841858},{"id":"https://openalex.org/keywords/splenomegaly","display_name":"splenomegaly","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.8939810991287231},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6886332035064697},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.575431227684021},{"id":"https://openalex.org/C2779929431","wikidata":"https://www.wikidata.org/wiki/Q2948600","display_name":"High-power field","level":3,"score":0.5414547920227051},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49934935569763184},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46467241644859314},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.46285027265548706},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4484425485134125},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.39691847562789917},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3844909369945526},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3581925630569458},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.3347880244255066},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.28827276825904846},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.5234.5234","doi":"https://doi.org/10.1182/blood.v112.11.5234.5234","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.5234.5234","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2125469922","https://openalex.org/W1198897879","https://openalex.org/W2556047502","https://openalex.org/W2085011517","https://openalex.org/W2133733019","https://openalex.org/W2550235848","https://openalex.org/W2048507165","https://openalex.org/W2791787272","https://openalex.org/W1998584331","https://openalex.org/W2282103947"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND:":[1],"THAL":[2,58,125,144,297,359,394,464,521,535,582,662],"has":[3,30],"been":[4,31,51],"used":[5],"as":[6],"immunomodulatory":[7,104],"therapy":[8,126,360,527,583],"alone":[9],"(Tefferi":[10],"et.":[11],"al.":[12,20],"Blood":[13],"200;96:4007),":[14],"or":[15,68,128,178,184,188,562,566],"with":[16,24,131,202,254,277,290,307,338,429,590,601,633,658],"steroids":[17],"(Mesa":[18],"et":[19],"Blood2003;101:2534),":[21],"in":[22,35,59,93,111,129,150,155,237,274,342,371,426,571,631,649],"patients":[23,84,121,276,289,370,428,518,586,600,632],"primary":[25],"myelofibrosis":[26],"(PMF).":[27],"Clinical":[28],"benefit":[29,593],"limited":[32],"to":[33,87,108,143,159,271,355,358,384,391,393,410,620],"improvements":[34],"cytopenias":[36,595],"and/or":[37],"splenomegaly.":[38],"However,":[39],"major":[40],"histologic":[41,249,333,405,552,578],"remissions":[42],"of":[43,46,55,57,76,83,119,166,190,207,216,225,227,287,301,331,364,398,402,423,517,534,558,569,613,640,645,656],"intramedullary":[44],"manifestations":[45],"disease":[47,657],"have":[48,71,385,608],"not":[49],"typically":[50],"observed.":[52],"The":[53],"mechanism":[54],"action":[56],"MF":[60,585],"remains":[61],"uncertain,":[62],"and":[63,89,97,106,136,141,164,180,186,213,241,258,273,309,328,387,596,598,661],"may":[64,99,648],"involve":[65],"cytokine":[66],"inhibition":[67],"immunomodulation.":[69],"We":[70,115],"previously":[72],"observed":[73],"increased":[74,602,611],"numbers":[75,226,345,542],"CD8+":[77],"T":[78,193,208,228,343,439,563],"lymphocytes":[79],"on":[80,205,577],"marrow":[81,245,528,603],"trephines":[82,147],"who":[85,122,264,315,519],"responded":[86],"THAL,":[88,266],"hypothesized":[90],"that":[91,336,368],"alterations":[92],"the":[94,214,299,399,538,541,572,643],"T-cell":[95,604,636],"distribution":[96],"population":[98],"provide":[100],"insight":[101],"into":[102],"an":[103,203,223,242],"response":[105,110,142,272],"correspond":[107],"subsequent":[109],"PMF":[112,120,255,291,325,377],"patients.":[113],"Methods:":[114],"analyzed":[116,137,554],"a":[117,151,156,312,339,524,609,626,634,652],"cohort":[118,286],"had":[123,323,523,574],"received":[124,265,296,317,520],"(alone":[127],"combination":[130],"corticosteroids)":[132],"from":[133,311,320],"our":[134],"institution":[135],"their":[138,302],"clinical":[139,160,592],"course":[140,300],"therapy.":[145],"Marrow":[146],"were":[148,172,195,251,282,351,374,380,388,543],"evaluated":[149],"systematic":[152],"fashion":[153,158],"(CYL":[154],"blinded":[157],"course)":[161],"for":[162,174,200,376,530,532,584,594,629],"cellularity":[163],"degree":[165,557],"reticulin":[167],"fibrosis":[168],"(0\u20134+).":[169],"Subsequently,":[170],"megakaryocytes":[171,373,641,647],"assessed":[173,196],"quantitative":[175],"(increased,":[176],"decreased,":[177],"normal)":[179],"qualitative":[181],"(size":[182],"(large":[183,219],"small)":[185,379],"presence":[187,644],"absence":[189],"morphologic":[191],"dysplasia).":[192],"cells":[194,229],"by":[197,417],"immunohistochemical":[198],"staining":[199],"CD8":[201],"emphasis":[204],"number":[206],"cell":[209,344,564],"clusters":[210,218,441],"per":[211,230,244,347],"trephine,":[212],"pattern":[215],"those":[217,263,275,369],"vs.":[220],"small).":[221],"Finally,":[222],"estimation":[224],"high":[231,348],"power":[232,349],"histology":[233,268],"field":[234],"was":[235,269,292,546],"conducted":[236],"3":[238,474,509],"distinct":[239],"areas,":[240],"average":[243],"trephine":[246],"obtained.":[247],"All":[248],"features":[250,334,406],"then":[252],"compared":[253,270],"prognostic":[256,326,400,579],"scores,":[257],"labs":[259],"at":[260,606],"presentation.":[261],"Amongst":[262],"baseline":[267,332,340,607],"serial":[278],"marrows":[279],"longitudinal":[280],"changes":[281],"assessed.":[283],"Results:":[284],"A":[285,515],"140":[288,427],"analyzed,":[293],"65":[294],"having":[295],"along":[298,306],"illness":[303],"(53":[304],"(82%)":[305],"prednisone)":[308],"75":[310],"comparison":[313,533],"group":[314],"never":[316],"THAL.":[318],"Patients":[319],"both":[321],"groups":[322],"similar":[324],"scores":[327],"presentations.":[329],"Comparison":[330,422],"demonstrated":[335,367],"individuals":[337],"increases":[341],"(>100":[346],"field)":[350],"significantly":[352,381],"more":[353,382,653,659],"likely":[354,383,390],"subsequently":[356],"respond":[357,392],"(p<0.01).":[361],"Additionally,":[362,638],"analysis":[363,531,617,639],"megakaryocyte":[365,560],"morphology":[366],"which":[372],"atypical":[375],"(i.e.":[378],"thrombocytopenia":[386,660],"less":[389],"(p=0.05).":[395],"Independent":[396],"assessment":[397],"value":[401],"these":[403],"individual":[404],"upon":[407,415,537,551],"survival":[408,416],"failed":[409],"reveal":[411],"any":[412],"direct":[413],"impact":[414,576],"Kaplan-Meier":[418],"Analysis.":[419],"Table":[420],"1.":[421],"Histologic":[424],"Features":[425],"Myelofibrosis":[430],"Group":[431],"Cell":[432,440],"Fibrosis":[433],"\u22653":[434],"Meg":[435,437],"Numbers":[436],"Size":[438],"T-Cells":[442],"(per":[443,447],"HPF)":[444,448],">100":[445],"Tcells":[446],"Control":[449],"(N=75)":[450],"72%":[451],"(10\u2013100)":[452],"33%":[453],"91%":[454],"Increased":[455,471,487,506],"21%":[456],"Small":[457,473,489,508],"4":[458],"(0\u201316)":[459],"median":[460,476,493,511],"80":[461],"(13\u2013258)":[462],"37%":[463],"ALL":[465],"(N=65)":[466],"60%":[467,483],"(5\u201395)":[468,484,503],"62%":[469],"79%":[470],"38%":[472],"(0\u201314)":[475,510],"93":[477],"(20\u2013500)":[478,513],"43%":[479],"-THAL":[480,498],"Responders":[481,500],"(N=28)":[482],"56%":[485],"82%":[486],"22%":[488],"(p=0.05)":[490],"5":[491],"(0\u201310)":[492],"113":[494],"(45\u2013198)":[495],"61%":[496],"(p<0.01)":[497],"Non":[499],"(N=37)":[501],"60":[502],"67%":[504],"76%":[505],"48%":[507],"70":[512],"26%":[514],"subgroup":[516],"(N=12)":[522],"second":[525],"post":[526],"available":[529],"effects":[536],"marrow,":[539],"although":[540],"small,":[544],"there":[545],"no":[547,575],"statistically":[548],"significant":[549,591],"differences":[550],"parameters":[553],"including":[555],"cellularity,":[556],"fibrosis,":[559],"morphology,":[561],"clustering":[565],"numbers.":[567],"Inclusion":[568],"prednisone":[570],"regimen":[573],"observations.":[580],"Conclusions:":[581],"can":[587],"be":[588],"associated":[589],"splenomegaly,":[597],"interestingly":[599],"populations":[605],"clear":[610],"likelihood":[612],"response.":[614],"Although":[615],"this":[616],"is":[618],"unable":[619],"gauge":[621],"mechanism,":[622],"it":[623],"would":[624],"suggests":[625,642],"greater":[627],"potential":[628],"immunomodulation":[630],"robust":[635],"population.":[637],"small":[646],"contrast":[650],"represent":[651],"resistant":[654],"phenotype":[655],"resistance.":[663]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-24T00:00:00"}